Portfolio company
Basilard Biotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Basilard Biotech develops gene delivery technology for cell and gene therapy manufacturers to facilitate nanomechanical engineering of cell-based treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
BlueWhale Bio
This company develops cell-derived nanoparticle technology to activate and expand immune cells for cell therapy manufacturers and clinical researchers.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
Indee Labs
Indee Labs develops microfluidic cell engineering instruments for pharmaceutical and biotechnology companies to deliver gene-editing materials into immune cells for therapeutic development.
Nanite
Nanite develops programmable polymer nanoparticles for non-viral gene delivery to support genetic medicine companies and patient advocacy groups.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
Mekonos
The company develops a silicon-based system-on-a-chip platform for automated ex vivo delivery of molecular cargo into individual cells for cell and gene therapy developers.
